What is the DSM-5 diagnostic criteria for OCD?
The DSM-5 defines OCD through the presence of obsessions, compulsions, or both, that consume more than one hour per day or cause clinically significant distress and functional impairment.
- Obsessions — recurrent, persistent, intrusive thoughts, urges, or images experienced as unwanted and ego-dystonic. The individual attempts to ignore, suppress, or neutralize them with another thought or action. Common themes include contamination, harm, symmetry, taboo sexual or religious content, and pathological doubt.
- Compulsions — repetitive behaviors (washing, checking, ordering) or mental acts (counting, praying, silently repeating) performed in response to an obsession. The behavior is aimed at preventing distress or a feared outcome but is either not realistically connected to the feared event or is clearly excessive.
- Insight specifier — DSM-5 codes good or fair insight, poor insight, or absent insight (delusional). Insight level influences treatment planning and prognosis.
The Yale-Brown Obsessive Compulsive Scale (Y-BOCS) is administered to measure severity and track treatment response across the 0–40 scale.
How does Exposure and Response Prevention (ERP) work?
ERP is the most rigorously studied psychotherapy in psychiatry, with response rates between 60% and 85% across meta-analyses by Foa, Abramowitz, and Olatunji. ERP is built on inhibitory learning theory and produces durable symptom reduction by extinguishing the obsession-anxiety-compulsion cycle.
- Hierarchy construction — patient and therapist collaboratively build an exposure hierarchy ranked by Subjective Units of Distress (SUDs), from low-trigger to high-trigger situations.
- In vivo exposure — direct, real-world contact with feared stimuli (touching a doorknob, leaving the stove unchecked, driving past a school).
- Imaginal exposure — scripted, vivid mental engagement with feared outcomes, used when in vivo is impractical or for taboo obsessions (harm, sexual, religious).
- Response prevention — patient refrains from the compulsion or neutralizing ritual during and after exposure, allowing anxiety to peak and naturally decline.
Standard course is 16–20 sessions; intensive ERP can compress this into 3–4 weeks. ERP is delivered individually, with homework assignments forming the core mechanism of change.
Questions About How does Exposure and?
Call our 24/7 admissions line or verify your insurance online.
Which SSRIs are first-line for OCD?
The American Psychiatric Association Practice Guideline names four SSRIs and one tricyclic as first-line pharmacotherapy for OCD, dosed substantially higher than for depression:
- Fluoxetine (Prozac) — FDA-approved for OCD, target dose 40–80 mg daily.
- Fluvoxamine (Luvox) — FDA-approved for OCD, target dose 200–300 mg daily.
- Sertraline (Zoloft) — FDA-approved for OCD, target dose 150–200 mg daily.
- Paroxetine (Paxil) — FDA-approved for OCD, target dose 40–60 mg daily.
- Clomipramine (Anafranil) — tricyclic antidepressant with the strongest single-agent evidence, reserved for SSRI non-responders due to side-effect burden.
Adequate trial duration is 10–12 weeks at target dose before declaring non-response. Augmentation with low-dose atypical antipsychotics (risperidone, aripiprazole) is APA-recommended for partial responders. ERP combined with SSRI produces superior outcomes to either alone for moderate-to-severe OCD.
“OCD is one of the most treatable disorders in psychiatry when ERP is delivered with fidelity and SSRIs are dosed appropriately. The most common reason patients fail prior treatment is inadequate ERP exposure or subtherapeutic medication dosing. We correct both — and treat the substance use that often masks the obsessional cycle.”
How does OCD treatment integrate with substance use disorder care?
The NESARC-III epidemiologic survey documents that 25–30% of individuals with OCD also meet criteria for substance use disorder, most commonly alcohol use disorder. Self-medication of obsessional anxiety is the predominant driver, with alcohol and benzodiazepines used to blunt distress between or during compulsions.
Integrated treatment is required because untreated OCD undermines SUD recovery, and active substance use blocks ERP engagement. Ascend coordinates ERP, SSRI prescribing, and SUD-focused therapy under a single clinical plan, with the same care team holding the chart.
Benzodiazepine use is specifically minimized because it interferes with the extinction learning that underlies ERP. SAMHSA TIP 42 documents that integrated dual diagnosis programs produce superior outcomes to sequential or parallel care for anxiety-spectrum disorders with SUD.